Delivery Order SPE2DR25D2014-SPE2DR26FA0W8
- Not listed
- The Defense Logistics Agency awarded a $2,337.94 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 10 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $1,038.89. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by December 11, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,472.70 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on December 29, 2025, with an ultimate completion date of December 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $7,137.99 delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) with a firm fixed price contract type. The award was made on December 18, 2025, with an ultimate completion date of December 19, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,110.21 on December 12, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement supporting federal medical supply needs. The ultimate completion date is December 15, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $3,160.25 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packaging) under a firm fixed price contract. The order, issued on December 29, 2025 with an ultimate completion date of December 30, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing pharmaceutical supply agreement with the federal government. The pharmaceutical product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,534.47. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by December 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $84,028.25 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) on December 17, 2025, with completion required by December 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,123.04 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's broader indefinite delivery vehicle with the DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract valued at $14,979.25. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0W8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Kerendia 10 mg tablets (90-count units) valued at $19,427.30. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order supports federal medical procurement needs, particularly for military and veteran healthcare systems under the Defense Logistics Agency's Medical Supply Chain. This award is issued as a child contract under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The ultimate completion date for this specific delivery order is December 30, 2025. As a major pharmaceutical distributor, AmerisourceBergen routinely fulfills federal contracts across multiple therapeutic domains, including specialty medications, vaccines, and medical devices, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 12/28/25 |